Diclofenac induced immune thrombocytopenia

Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada.
The Journal of Rheumatology (Impact Factor: 3.19). 11/1990; 17(10):1403-4.
Source: PubMed


We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions. Platelet count returned to normal with cessation of diclofenac and institution of prednisone.

45 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A case of diclofenac-induced thrombocytopenic purpura in a 59-year-old woman is described. Unlike the majority of earlier cases, ours was associated with renal insufficiency and jaundice. Despite the dramatic clinical picture, with severe thrombocytopenia and marked renal insufficiency, the prognosis appears to be excellent, as is shown in our case and in similar ones reported in the literature. A high dose of steroids is the treatment of choice.
    Journal of Internal Medicine 01/1992; 230(6):543-7. DOI:10.1111/j.1365-2796.1991.tb00487.x · 6.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Serious idiosyncratic hepatic injury has been associated with the use of many nonsteroidal antiinflammatory drugs, including the widely prescribed agent diclofenac. In order to investigate the possibility that covalent protein adducts of reactive metabolites of diclofenac might be responsible for the hepatotoxicity produced by this drug, we have developed a polyclonal antibody that can recognize such adducts in tissues. Immunoblotting revealed that protein adducts of reactive metabolites of diclofenac of 50, 70, 110, and 140 kDa were formed in the livers of mice treated with diclofenac. In the future, it will be determined whether these adducts can cause hepatotoxicity by either a hypersensitivity or metabolic mechanism. Similar approaches may be used to study the protein adducts and mechanisms of hepatotoxicity of other nonsteroidal antiinflammatory drugs.
    Chemical Research in Toxicology 03/1993; 6(2):147-50. DOI:10.1021/tx00032a002 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Immune-mediated reactions to NSAIDs are unusual. We have observed two cases of maculopapular eruptions occurring 48-72 h after administration of diclofenac sodium. Patch tests performed with diclofenac were positive. The histopathologic findings resembled those of contact dermatitis with different degrees of dermal involvement. Clinical, allergologic, and histopathologic patterns strongly suggest a type IV mechanism of hypersensitivity. Patch tests play an important role in the assessment of possible immunologic mechanisms underlying cutaneous reactions to drugs.
    Allergy 02/1994; 49(1):57-9. DOI:10.1111/j.1398-9995.1994.tb00774.x · 6.03 Impact Factor
Show more